Compare PRAA & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRAA | NPCE |
|---|---|---|
| Founded | 1996 | 1997 |
| Country | United States | United States |
| Employees | 170 | N/A |
| Industry | Finance: Consumer Services | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 639.1M | 576.9M |
| IPO Year | 2002 | 2021 |
| Metric | PRAA | NPCE |
|---|---|---|
| Price | $15.63 | $16.28 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $24.50 | $18.33 |
| AVG Volume (30 Days) | ★ 577.0K | 184.1K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.03 |
| EPS | ★ 0.73 | N/A |
| Revenue | ★ $1,201,837,000.00 | $99,986,000.00 |
| Revenue This Year | $2.01 | $0.90 |
| Revenue Next Year | $2.53 | $24.46 |
| P/E Ratio | $20.60 | ★ N/A |
| Revenue Growth | 7.83 | ★ 25.13 |
| 52 Week Low | $10.25 | $7.56 |
| 52 Week High | $22.55 | $19.60 |
| Indicator | PRAA | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 44.31 | 47.42 |
| Support Level | $15.04 | $15.40 |
| Resistance Level | $15.76 | $17.37 |
| Average True Range (ATR) | 0.71 | 0.79 |
| MACD | 0.12 | -0.09 |
| Stochastic Oscillator | 89.50 | 31.26 |
PRA Group Inc is a leader in acquiring and collecting nonperforming loans. The company returns capital to banks and other creditors to help expand financial services for consumers in the Americas, Europe, and Australia. It is also engaged in providing fee-based services on class action claims recoveries in the United States. The company's portfolio segments include; Core, which is engaged in purchasing and collecting nonperforming loans, which the originators have not chosen not to pursue, and the Insolvency segment which is engaged in purchasing and collecting nonperforming loans where the customer is involved in a bankruptcy proceeding.
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.